The in vivo utilization of D-[U-14C]glucose with particular reference to its incorporation into brain and liver proteins was studied in biotin-deficient rats. The data show a significant reduction in the incorporation of glucose carbon into brain and liver proteins . A dis turbance in the intermediary metabolism of glucose appears to be one of the factors responsible for the decreased incorporation of the label into proteins in biotin deficiency.
RESULTS
The growth rate of the deficient animals was very poor and levelled off by about six weeks on the diet. In addition to a marked difference in body and liver weights, brain weights were also significantly lower in the deficient rats as reported previously (16) .
Since fasted animals were used in the studies , data on the blood glucose con tent in rats treated with a tracer dose of glucose actually represent baseline fasting values (Table 1) . The fasting blood glucose contents were found to be significantly lower in the deficient animals, as reported previously (10 , 13, 17) . This difference was not seen in animals administered carrier doses of labelled glucose (100mg/100g body weight) except for a slight decrease in the deficient animals at one hour following injection. While the total radioactivity and glucose radioactivity per ml blood and the specific radioactivity (DPM/mg blood glucose) were lower in the deficient animals in the tracer experiments, there was no significant difference in these values between the deficient and control rats in the carrier experiments , with the exception of the one hour group with respect to glucose radioactivity . Further more, the decline in these values from 0.5 hr to 2 hr was more rapid in both the deficient and control rats in the tracer than in the carrier experiments . The deficient animals had a much lower concentration of glucose in the liver as compared with the controls in both the tracer and carrier experiments ( Table 2 ). Both the groups showed an increase in liver glucose following administration of carrier doses of glucose, the increase being much greater in the control rats. While the total and glucose radioactivity per g liver were significantly lower in both the tracer and carrier experiments at all the time intervals in the deficient rats, the specific radioactivity of glucose (DPM/mg glucose) did not differ from that of the controls.
The incorporation of glucose radioactivity into brain and liver proteins was significantly lower in the biotin-deficient rats with both tracer (Table 3) and carrier (Table 4 ) doses of labelled glucose as seen by lower values for protein radio activity (per g tissue) and specific radioactivity (DPM/mg protein). There was no difference in the protein content of brain or liver between the deficient and control animals as reported previously (18) .
DISCUSSION
In the tracer glucose study blood glucose content, which represents fasting glucose values, showed a significant reduction in the deficient animals. This is consistent with previous reports of fasting hypoglycemia in biotin deficiency (10, 13, 17) . The total and glucose radioactivity per ml blood, and the specific radio activity were also significantly lower in the deficient animals. Since tracer doses of glucose were administered in this study, the effect of the treatment on the endogenous glucose pool was negligible. If the change in glucose radioactivity is taken to reflect the overall rate of glucose utilization under endogenous conditions, then the deficient rats appear to show a faster clearance of circulating glucose. This is in support of the findings of DEODHAR and MISTRY (19) who have suggested increased glycolysis in biotin-deficient rat livers.
The rate of decrease in the specific radioactivity of glucose does not show any apparent difference between the deficient and control rats. This, however , may be attributed to decreased dilution of labelled glucose with endogenously synthesized glucose in the deficient animals. Previous data show a decreased rate of gluconeogenesis in biotin deficient animals (10, 13, 20) . If a correction could be applied for this difference in gluconeogenesis between the deficient and control rats, then the rate of change in the specific radioactivity of glucose might also show a similar trend as in the case of glucose radioactivity. When carrier doses of glucose are administered, the differences between the two groups with respect to the above measures are masked. It may be noted that in this study the glucose content of blood at the three intervals is representative of a typical "glucose toler ance" experiment. These data show the deficient animals to be at least as efficient as the controls, whereas the tracer experiment indicates the deficient rats to be superior to the controls in the rate of clearance of circulating glucose . The endogenous glucose content of liver was also significantly lower in the deficient rats as compared with the controls (tracer study). This is again con sistent with decreased gluconeogenesis in biotin deficiency (10, 13) , which can be attributed to reduced activity of the biotin-dependent enzyme pyruvate carboxy lase (21, 22) . The total and glucose radioactivity per g liver were also signifi cantly lower, but the specific radioactivity of glucose was not altered. The data with carrier doses of glucose are quite similar to the above findings. Of signifi cance is the observation that the glucose content of livers of control animals were much higher than those of the deficient animals at all the three intervals, which may again suggest differences in glucose utilization in biotin deficiency.
The incorporation of glucose carbon into both brain and liver proteins was significantly reduced in the deficient animals, as seen by the protein DPM per g tissue and by the specific radioactivity of the isolated proteins in both the tracer and carrier experiments. There was no difference in the protein concentra tions in either the brain or liver between the two groups as reported earlier (18) . The incorporation of the label into proteins of the brain continued to show a rise INTO BRAIN & LIVER PROTEINS 85 over the two hour period. In the case of liver, the incorporation plateaued at the end of one hour with tracer doses of glucose but not with carrier doses , in both the groups. When the protein DPM, expressed as a percent of total DPM in the tissue, is employed to assess the "efficiency" of incorporation of the label into proteins, the ratio was found to be significantly lower in the brains of deficient animals in the carrier study, but not in the tracer study . In the case of the liver, no statistically significant differences were seen between the deficient and control groups in either the tracer or carrier study. These data indicate that label taken up by brain and liver was not utilized to the same extent in the deficient rats as compared with the controls with respect to its incorporation into proteins . This is particularly so in the carrier experiments. It may also be noted that while the uptake of the label by liver per unit weight was lower in the deficient animals in both the tracer and carrier experiments, there was no significant difference in the specific radioactivity of glucose. Hence the decreased incorporation of the glucose carbon into the proteins may be attributed to differences in the utilization of glucose between the deficient and control rats. The rapid flux of glucose carbon into amino acids is a well recognized char acteristic of the brain (viz. [1] [2] [3] [4] 23) . The enzymes metabolizing glucose in the brain are regulated in such a way that glucose is rapidly metabolized and then the glucose carbon is transferred through the a-keto acids of the TCA cycle to the amino acid pool (24, 25) . The present data which show that the rate of incorpora tion of glucose carbon into proteins during the two hour period is higher in brain than in liver in the control as well as in the deficient rats is consistent with the above observations. This difference between the brain and liver is seen in both the tracer and carrier experiments.
The importance of carbon dioxide fixation and particularly of pyruvate carboxylase in the regulation of pyruvate metabolism in the brain has been re cently demonstrated (26, 27) . Pyruvate carboxylase plays a key role in the pro duction of [C4]-compounds involved in the net synthesis of TCA intermediates and dicarboxylic amino acids. Since pyruvate carboxylase is a biotin-dependent enzyme (28) , biotin deficiency leads to a decreased utilization of pyruvate (21; H. N. Bhagavan, unpublished data). This results in an accumulation of pyruvate (5, 13; H. N. Bhagavan, unpublished data) and a decreased production of malate (oxalacetate), citrate (13) and possibly of a-ketoglutarate in the tissues. While the specific activities of the various keto acids and the corresponding amino acids were not determined in this study, it is quite conceivable that significant differences between the deficient and control rats would have been observed , since the TCA intermediates are directly involved in the transfer of glucose carbon to amino acids. Furthermore, although it is not known whether any of the amino acid transferases if affected in biotin deficiency, decreased production of the TCA intermediates per se would account for the reduced incorporation of glucose carbon into proteins. In addition, previous data also show decreased incorpora tion of labelled amino acids into brain (18) and liver proteins (18, 29) in biotin deficient rats. The more recent findings of DAKSHINAMURTI and LITVAK (30) suggest a role for biotin in protein synthesis at the level of nuclear RNA synthesis. These data thus indicate that the decreased incorporation of glucose carbon into proteins may be explained on the basis of the effect of the deficiency on more than one intermediate step involved in the synthesis of protein from glucose.
Although the depletion of biotin from the brain (about 50%) is much less in comparison to that from the liver (over 90%) in post-weanling biotin-deficient rats (16) , the extent of the decrease in the incorporation of glucose carbon into proteins in brain is not that different from that in liver. This suggests a more severe effect on the brain with a much less depletion of biotin as compared with the liver. In view of this, it would appear that the effects of the deficiency on the developing brain induced by either maternal or neonatal biotin deficiency would be far more severe with respect to in vivo protein synthesis and perhaps several other pathways where biotin is directly involved.
